N-[(1S)-1-[3-(5-fluoro-3-pyridinyl)phenyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine
C27H23FN4O — CID 127036127
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1S)-1-[3-(5-fluoro-3-pyridinyl)phenyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine
N-[(1S)-1-[3-(5-fluoro-3-pyridinyl)phenyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine (PubChem CID 127036127) has the molecular formula C27H23FN4O and a molecular weight of 438.51 g/mol. Its IUPAC name is N-[(1S)-1-[3-(5-fluoro-3-pyridinyl)phenyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine.
Molecular Properties
| Compound Name | N-[(1S)-1-[3-(5-fluoro-3-pyridinyl)phenyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine |
|---|---|
| PubChem CID | 127036127 |
| Molecular Formula | C27H23FN4O |
| Molecular Weight | 438.51 g/mol |
| Exact Mass | 438.19 |
| IUPAC Name | N-[(1S)-1-[3-(5-fluoro-3-pyridinyl)phenyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine |
| SMILES | Cc1nc(N[C@@H](C)c2cccc(-c3cncc(F)c3)c2)cc(-c2ccc3occ(C)c3c2)n1 |
| InChI | InChI=1S/C27H23FN4O/c1-16-15-33-26-8-7-21(11-24(16)26)25-12-27(32-18(3)31-25)30-17(2)19-5-4-6-20(9-19)22-10-23(28)14-29-13-22/h4-15,17H,1-3H3,(H,30,31,32)/t17-/m0/s1 |
| InChIKey | PTBPSZQFLGNTSK-KRWDZBQOSA-N |
| XLogP | 6.88 |
| TPSA | 63.84 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 438.51 |
| LogP ≤ 5 | 6.88 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 127036127 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.